2.85
4.04%
-0.12
Dopo l'orario di chiusura:
2.87
0.02
+0.70%
Organogenesis Holdings Inc Azioni (ORGO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
8.18%
99.65
|
108.53 | 117.32 | 107.64 | 115.52 |
Cost Of Revenue |
7.68%
27.77
|
25.79 | 26.32 | 26.61 | 27.11 |
Gross Profit |
13.13%
71.88
|
82.74 | 91.00 | 81.03 | 88.41 |
Operating Expenses
|
2.06%
73.15
|
74.69 | 81.25 | 85.04 | 79.69 |
Interest Income/Expense |
13.06%
0.502
|
0.444 | 0.594 | 0.649 | -0.03 |
Benefits Costs and Expenses |
0.55%
101.45
|
100.89 | 108.14 | 112.27 | 106.76 |
Costs And Expenses |
0.55%
101.45
|
100.89 | 108.14 | 112.27 | 106.76 |
Operating Income/Loss |
115.76%
-1.269
|
8.05 | 9.745 | -4.001 | 8.718 |
Nonoperating Income/Loss |
27.60%
-0.527
|
-0.413 | -0.566 | -0.626 | 0.036 |
Income/Loss From Continuing Operations Before Tax |
123.52%
-1.796
|
7.637 | 9.179 | -4.627 | 8.754 |
Income Tax Expense/Benefit |
127.47%
-1.228
|
4.47 | 3.863 | -1.658 | 1.268 |
Income/Loss From Continuing Operations After Tax |
117.93%
-0.568
|
3.167 | 5.316 | -2.969 | 7.486 |
Net Income/Loss
|
117.93%
-0.568
|
3.167 | 5.316 | -2.969 | 7.486 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
100.00%
0.000435
|
131.31 | 131.29 | 131.08 | 0.2853 |
Diluted Average Shares |
100.03%
-0.0436
|
133.42 | 133.07 | 131.08 | -0.1721 |
Basic Earnings Per Share |
100.00%
-
|
0.02 | 0.04 | -0.02 | 0.06 |
Diluted Earnings Per Share |
100.00%
-
|
0.02 | 0.04 | -0.02 | 0.06 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):